Company
ORCA Therapeutics
- Biotech
- Headquarters:
- 's-Hertogenbosch
Description
ORCA Therapeutics develops oncolytic virus immunotherapies for prostate cancer, producing lead therapeutic ORCA-010 for treatment-naive patients and related oncolytic replication competent agents for oncology clinical use.
Related
Faron Pharmaceuticals Ltd.Faron Pharmaceuticals Ltd. develops immunotherapies that leverage patients' immune systems for cancer treatment, serving clinical…
TILT BiotherapeuticsTILT Biotherapeutics develops oncolytic viral immunotherapies that modify the tumor microenvironment to stimulate T‑cell responses and…
CiMaasCiMaas develops cellular immunotherapies using expanded Natural Killer (NK) cells as advanced therapeutic products for cancer patients and…
NKINKI conducts cancer research and provides patient care, developing fundamental, translational and clinical research, technologies and…
BioNTechBioNTech develops immunotherapies and mRNA vaccines for cancer, infectious diseases and other serious illnesses, serving patients through…
OncoGenOncoGen conducts research and microproduction for cancer, allergies and regenerative medicine, developing gene‑cell therapies, anti‑cancer…
OncolinesOncolines provides precision-medicine services that profile cancer biology to guide oncology and cancer immunotherapy development, offering…
Vivere OncotherapiesVivere Oncotherapies develops bioengineered cancer immunotherapies designed to help patients’ immune systems target cold tumors and support…
XENOTHERAXENOTHERA develops glyco-humanized antibody therapeutics and related immunological treatments for clinical use, pursuing products in…
Karyopharm Therapeutics ($KPTI)Karyopharm Therapeutics develops and commercializes cancer therapies, including oral nuclear export inhibitors, for patients with multiple…
TareBioTareBio develops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment…
HAL AllergyHAL Allergy develops, produces and distributes allergen immunotherapies and modified allergen extracts for therapeutic and diagnostic use,…